Ming Chu
Impact in
- Pharmacology top 10%
- Berberine and alkaloids research
- Flavonoids in Medical Research
- Periodontics top 10%
- Oral microbiology and periodontitis research
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
- Oncology 6
- Cancer-related Molecular Pathways 2
- Co-authors
- Yuedan Wang (13 shared papers)Zheng-yun Chu (7 shared papers)Mingbo Zhang (3 shared papers)Yimiao Zhu (1 shared paper)Zhou Zhou (1 shared paper)Ran Ding (2 shared papers)Lan Xu (3 shared papers)Yuedan Wang (11 shared papers)
- Journals
- Frontiers in Pharmacology (5 papers)PLoS ONE (3 papers)Frontiers in Immunology (3 papers)Frontiers in Oncology (2 papers)Biomicrofluidics (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ming Chu
46 papers receiving 876 citations
Peers
Comparison fields: 5 of 69
- Pharmacology 88
- Periodontics 31
- Infectious Diseases 74
- Health, Toxicology and Mutagenesis 45
- Immunology 34
Countries citing papers authored by Ming Chu
This map shows the geographic impact of Ming Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Chu more than expected).
Fields of papers citing papers by Ming Chu
This network shows the impact of papers produced by Ming Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Chu. The network helps show where Ming Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 107 | |
| 2 | 2014 | 91 | |
| 3 | 2017 | 87 | |
| 4 | 2015 | 74 | |
| 5 | 2022 | 68 | |
| 6 | 2015 | 45 | |
| 7 | 2018 | 34 | |
| 8 | 2018 | 31 | |
| 9 | 2022 | 30 | |
| 10 | 2013 | 28 | |
| 11 | 2022 | 21 | |
| 12 | 2023 | 21 | |
| 13 | 2008 | 20 | |
| 14 | 2015 | 20 | |
| 15 | 2022 | 18 | |
| 16 | 2021 | 15 | |
| 17 | 2022 | 13 | |
| 18 | 2022 | 11 | |
| 19 | 2016 | 10 | |
| 20 | 2022 | 10 |
About Ming Chu
Ming Chu is a scholar working on Infectious Diseases, Oncology, Periodontics, Pharmacology and Dermatology, having authored 50 papers that have together received 892 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Berberine and alkaloids research (3 papers), Oral microbiology and periodontitis research (3 papers), Dermatology and Skin Diseases (2 papers), Cancer-related Molecular Pathways (2 papers), Pesticide Exposure and Toxicity (1 paper), Inflammatory Bowel Disease (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Pharmacology (88 citations), Periodontics (31 citations), Infectious Diseases (74 citations), Health, Toxicology and Mutagenesis (45 citations) and Immunology (34 citations). Ming Chu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yuedan Wang, Zheng-yun Chu, Mingbo Zhang, Yimiao Zhu, Zhou Zhou, Ran Ding, Lan Xu, Yuedan Wang, Jiarui Kang and Mingbo Zhang. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, Frontiers in Immunology, Frontiers in Oncology and Biomicrofluidics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.